USP publishes list of vulnerable medicines susceptible to shortages
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyGenericsPharmaceuticalsRisk managementShortagesSterile drugsSupply Chain ManagementUnited StatesUS Food and Drug Administration (FDA)WHO